search
for
 About Bioline  All Journals  Testimonials  Membership  News


Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 4, Num. 4, 2005, pp. 154-159

Annals of African Medicine, Vol. 4, No. 4, 2005, pp. 154-159

SMALL-FOR-GESTATIONAL AGE, PONDERAL INDEX AND NEONATAL POLYCYTHAEMIA: A STUDY OF THEIR ASSOCIATION WITH MATERNAL HYPERTENSION AMONG NIGERIAN WOMEN

A. N. Onyiriuka and A. A. Okolo

Department of Child Health, College of Medical Sciences, University of Benin, Benin City, Nigeria
Reprint requests to: Dr. A. N. Onyiruka, Department of Child Health, University of Benin Teaching Hospital, P. M. B. 1111, Benin City, Nigeria

Code Number: am05039

Abstract

Background/Objective: To examine the influence of maternal hypertension on rate of delivery of small-for-gestation age (SGA) infants, incidence of neonatal polycythaemia and mean ponderal indices of the resultant newborn infants.
Methods:From the birth weights and lengths, the ponderal indices of SGA infants born to mothers with chronic hypertension were compared with those of their counterparts born to mothers with pregnancy–induced hypertension. In addition, the spun venous haematocrit values of 265 infants born to mothers whose pregnancies were complicated by hypertension were compared with those of 804 infants born to control mothers.
Results: The rates of delivery of SGA infants were 82.0 and 54.7 per 1000 live births among hypertensive and normotensive mothers respectively (p>0.05). The prevalence of neonatal polycythaemia was 8.2% and 2.2% for infants of hypertensive and control mothers respectively (p<0.001). The rate of delivery of SGA infants was 18.6 times higher in mothers with chronic hypertension than in mothers with pregnancy-induced hypertension (p<0.001). SGA infants born to mothers with chronic hypertension had normal mean ponderal index (≥2.3) while their counterparts born to mothers with pregnancy-induced hypertension had low mean ponderal index (<2.3). The prevalence of neonatal polycythaemia was 52.9% and 5.0% in infants born to mothers with chronic hypertension and infant of mothers with pregnancy-induced hypertension respectively (p<0.001).
Conclusion:Maternal hypertension is associated with an increased incidence of neonatal polycythaemia and delivery of SGA infants.  This risk is dramatically higher in women with chronic hypertension. Chronic maternal hypertension causes proportionate foetal growth retardation while pregnancy-induced hypertension causes disproportionate foetal growth retardation.

Key words: Maternal hypertension, small for gestational age, ponderal index, neonatal polycythaemia

Résumé

Contexte/Objectifs: Examinerl’influence de l’hypertension maternelle sur le taux d’accouchement de nouveaux-nés petits par rapport à l’âge gestationnel, l’incidence de la polycytémie néonatale et l’indice de poids moyen des nouveaux-nés résultant. 
Méthodes: A partir de la longueur et du poids de naissance, l’indice pondéral d’enfants petits par rapport à l’âge gestationnel nés de mères souffrant d’hypertension chronique a été comparé à celui d’enfants nés de mères ayant une hypertension gravidique. De même la valeur de l’hématocrite de sang centrifugé de 265 enfants nés de mères dont la grossesse s’était compliquée d’hypertension a été comparée à celle de 804 enfants nés de mères témoins.
Résultats :Le taux d’accouchement d’enfants petits par rapport au poids de naissance était de 82 et de 54,7 pour1000 naissances vivantes, respectivement pour les mères hypertendues et les mères normotendues (p>0.05). La prévalence de la polycythémie néonatale était respectivement de 8,2% et 2,2% pour les enfants de mères hypertendues et les témoins (p<0.001). Le taux d’accouchement d’enfants petits par rapport à l’âge gestationnel était 18,6 fois plus élevé chez les femmes souffrant d’hypertension chronique par rapport aux mères ayant une hypertension gravidique (p<0.001). Les enfants petits par rapport à l’âge gestationnel nés de mères souffrant d’hypertension chronique avaient un index pondéral moyen normal (≥ 2.3), tandis que leurs homologues nés de mères souffrant d’hypertension gravidique avaient un faible index pondéral moyen (<2.3). La prévalence de polycythèmie néonatale était de 52,9% et 5,0% pour les enfants nés respectivement de mères souffrant d’hypertension chronique et de mères souffrant d’hypertension gravidique (p<0.001).
Conclusion : Une hypertension maternelle est associée à une incidence élevée de polycythémie néonatale et à un accouchement de nouveaux nés petits par rapport à l’âge gestationnel. Ce risque est dramatiquement plus élevé chez les femmes souffrant d’hypertension chronique. L’hypertension chronique maternelle entraîne un retard proportionné de croissance foetal, tandis que l’hypertension gravidique entraîne un retard dysproportionné de croissance foetal.

Mots Clés:Hypertension maternelle, petit par rapport à l’âge gestationnel, index pondéral, polycythémie néonatale

Introduction

Hypertension is estimated to complicate approximately 7-10% of pregnancies.1 In some instances, the disease precedes pregnancy while in others it occurs as a complication of pregnancy. Hypertensive disorders in pregnancy (HDP) are believed to predispose to acute or chronic utero-placental insufficiency. In fact, Gant and Worley have observed that in patients with hypertension in pregnancy the utero-placental blood flow drops to 50-65% after 3 to 4 weeks of the disease.2 Shallow trophoblastic invasion of the decidual arteries can precipitate pre-eclampsia, reduce placental perfusion and cause insufficient transport of nutrients.3 Thus, the resultant utero-placental insufficiency and insufficient transport of nutrients in HDP lead to foetal growth restriction.

There exist various body proportionality indices of which the Rohrer’s ponderal index is the most useful in categorizing growth-retarded foetuses into proportionate and disproportionate subgroups.4-7 The use of ponderal index as a body proportionality index at birth has some advantages. First, it can capture information about timing of the growth retardation as well as the nutritional status of the newborn.4, 5-7 Secondly, it is useful for predicting outcome in small-for-gestational age (SGA) babies, particularly where there is no reliable information on gestational age.4, 5

It is well known that relative foetal hypoxia stimulates the release of erythropoietin, which in turn promotes erythropoiesis thereby leading to neonatal polycythaemia.8-10 In fact, Brazy et al11 have reported that venous haematocrits after birth averaged 5% higher in infants of hypertensive mothers than in those of normotensive mothers. However, they neither stated the prevalence of neonatal polycythaemia among infants born to hypertensive mothers nor the subtype of HDP associated with highest risk.

The purpose of this study is to determine the incidence of SGA and neonatal polycythaemia in the resultant newborn infants of hypertensive mothers and to examine which subtype of HDP is associated with higher prevalence of SGA and neonatal polycythaemia. In addition, to compare the ponderal indices of growth retarded babies born to mothers with chronic hypertension with those of their counterparts born to mothers with pregnancy induced-hypertension.

Patients and Methods 

All Nigerian mothers with HDP who presented at the University of Benin Teaching Hospital (UBTH) during the two-and-half year study period (1st January 1992 to 30th June 1994) were recruited into the study. For each case of maternal hypertension, three consecutively admitted healthy normotensive pregnant Nigerian mothers were recruited as controls following informed verbal consent. The rate of delivery of SGA infants and the haematocrit values of the resultant newborn infants of both groups of mothers were compared. The rate of delivery of SGA infants with their ponderal indices and the prevalence of neonatal polycythaemia in babies born to mothers with chronic hypertension were compared with those of their counterparts born to mother with pregnancy-induced hypertension. Criteria for diagnosis of HDP and inclusion into the study were:

  1. A documented history of hypertension (blood pressure (BP≥140/90mmHg before pregnancy12).
  2. An increase in either systolic or diastolic BP > 30mmHg or 15mmHg respectively above the booking BP.12
  3. An intrapartum BP ≥ 140/90mmHg obtained on at least two occasions not less than six hours apart during delivery.12
  4. Mothers of control infants were normotensive throughout pregnancy and upon admission for delivery. They also had no known exposure to diuretics and drugs with anti-hypertensive properties.
  5. Both groups of mothers did not smoke and were free of major diseases such as diabetes mellitus, sickle-cell anaemia, renal failure, heart diseases and bronchial asthma. Twin pregnancies were also excluded.
  6. None of the pairs of groups differed significantly in terms of maternal height, marital or socio-economic status. Socio-economic status (social class) was obtained through a scoring index combining a woman’s level of education with the occupation if her husband, which allocates each woman to social class I to V, social class V being at the bottom of the social stratification. The suitability and application of this Social Classification System for our environment have been well-tested and presented elsewhere.13
  7. Both groups of infants did not have delayed clamping of the cord, post-maturity, Beckwith’s syndrome, neonatal thyrotoxicosis and dysmorphic features suggestive of genetic trisomies such as trisomies 13, 18 and 21.

In the classification of HDP, the method recommended by Khan14 was used because it was more closely related to the methods adopted.

Patients whose hypertension started early in pregnancy were identified and subsequently followed up closely by the obstetrician as an outpatient unless they develop complications requiring hospitalisation. Clinic visits were scheduled fortnightly until 32 weeks of gestation and weekly thereafter. At each visit, the BP and urine test for protein was performed using albustix(R) and the results were recorded.

Gestational age was determined by maternal dates and by a Dubowitz et al15 gestational age examination of the infant 12 to 24 hours after birth by one of the authors (ANO). If a discrepancy of more than two weeks existed, the gestational age was assigned from the Dubowitz score. The babies were weighed naked using a Waymaster weighing scale. The scale was standardized with known weights and was checked daily for zero error. The birth length was measured using Holtain infant measuring table. All measurements were carried out within the first two hours of birth. From the birth weight and length data so obtained, the Rohrer’s ponderal indices4 of all SGA babies were calculated. The mean ponderal index of SGA babies born to mothers with chronic hypertension was compared with that of babies born to mothers with pregnancy-induced hypertension using Miller and Hassanein criteria.16 The haematocrit values of all infants were determined by one of the authors (ANO) using venous blood sample obtained from antecubital vein as recommended by Guha17 and Letsky.18 Spun haematocrit values were used for screening as recommended by Letsky.18

The following terms have been defined:

  1. Neonatal polycythaemia refers to venous haematocrit ≥ 65% on two samples taken from a large free flowing antecubital vein.17,18
  2. SGA infants are infants whose birth weights were below 2 standard deviation for gestational age by Olowe’s charts.19
  3. Rohrer’s ponderal index = 100 times the birth weight in grammes divided by the cube of the birth length in centimetres.4
  4. Chronic hypertension is defined as hypertension present before the 20th week of pregnancy or  hypertension present before pregnancy.12
  5. Pregnancy-induced hypertension refers to hypertension beginning after 20th week of pregnancy.12

Z-test was used in ascertaining the level of significance of differences, which was set at p<0.05.

Results

Of the 3780 pregnancies delivered during the study period, 272 (7.2%) were complicated by hypertension. Out of the 272 babies delivered by hypertensive mothers, 16(5.9%) were stillbirths: 11(68.8%) were fresh while the remaining 5(31.2%) were macerated stillbirths. Of the 816 babies delivered by normotensive mothers, 12(1.5%) were stillbirths: 5(14.7) were fresh while the remaining 7(58.3%) were macerated stillbirths (stillbirth rate: study group versus control group Z-statistic = 14.071 p<0.001). Available for analysis, therefore, were 256 and 804 live babies delivered by hypertensive and normotensive mothers respectively. Transient hypertension was present in 19 (0.5%),mild to moderate pre-eclampsia 123 (3.3%) severe pre-eclampsia 89 (2.3%), eclampsia 13 (0.6%), chronic hypertension 13 (0.3%), and chronic hypertension with superimposed pre-eclampsia 7 (0.2%).

Table 1 shows that the risk of delivery of an SGA infant was 1.5 times higher in pregnancies complicated by hypertension than in control pregnancies. The table also shows that the subtype of HDP associated with the highest incidence of delivery of an SGA infant was chronic hyprtension with superimposed pre-eclampsia.

Tables 2 and 3 show that the prevalence of neonatal polycythaemia was 3.7 times in infants born after hypertensive than in control pregnancies.

Table 4 shows that the rate of delivery of an SGA infant was 18.6 times higher in mothers with chronic hypertension than in their counterparts with pregnancy-induced hypertension (Z-statistic=6.008 p<0.001).It also shows that SGA infants born to mothers with chronic hypertension had normal mean ponderal index, indicating proportionate foetal growth retardation while their counterparts born to mothers with pregnancy-induced hypertension had low mean poderal index, indicating disproportionate foetal growth retardation . The prevalence of neonatal polycythaemia was 10.5 times higher in infants born to mothers with chronic hypertension than in their counterparts born to mothers with pregnancy-induced hypertension (Z-statistic= 3.930 p0<0.001).

Table 1: Distribution of SGA infants according to subtype of hypertensive disorder in pregnancy

Type of HDP

Total No. Newborn infants

No. Live-newborn infants

SGA Infants

No.

(Rate per 1000 live birth)

Transient hypertension

19

19

0

0

Mild to moderate pre-eclampsia

123

122

2

(16.0)

Severe pre-eclampsia

89

82

7

(95.0)

Eclampsia

21

16

0

0

Chronic hypertension

13

13

8

(538.0)

Chronic hypertension with superimposed pre-eclampsia

7

4

4

(1000)

Total study group

272

256

21

(82.0)

Total control group

816

804

44

(54.7)

SGA delivery rate in HDP versus control group: Z-statistic= 1.481p>0.05

Table 2: Comparison of prevalence of neonatal polycythaemia in infants of hypertensive mothers and in control group

Variable assessed

Infant of  hypertensive mothers

Infants of control mothers

No. of live-births

256

804

 No. with polycthaemia*

21

18

Prevalence (%) of polycythaemia

8.2

2.2

* Z-statistic = 13.676 p<0.001 

Table 3:  Prevalence of neonatal polycythaemia according to subtypes of hypertensive disorder in pregnancy

Type of HDP

No. of live-birth

No. with polycythaemia

Prevalence (%) of polycythaemia

Transient hypertension

19

1

5.3

Mild to moderate pre-eclampsia

122

4

3.3

Severe pre-eclampsia

82

6

7.3

Eclampsia

16

1

6.3

Chronic hypertension

13

7

53.8

Chronic hypertension with superimposed pre-eclampsia

4

2

50.0

Total study group

256

21

8.2

Total control group

804

18

2.2

Table 4: Comparison of rates of SGA delivery, mean ponderal indices and prevalence of neonatal polycythaemia in infants born to mothers with chronic hypertension and in infants born to mothers with pregnancy-induced hypertension

Variables assessed

Type of maternal hypertension

Chronic hypertension

Pregnancy-induced hypertension

No. of live-births

17

239

No. of SGA infants

12

9

SGA delivery rate per 1000 live births

706.0

38.00

Mean ponderal index ± SD

2.45±0.14

2.29±0.17

Range of ponderal index

2.38-2.55

2.20-2.47

No with polycythaemia

9

12

Incidence (%) of polycythaemia

52.9

5.0

Discussion

The higher rate if delivery of an SGA infant in hypertensive than in control pregnancies reported here is in keeping with the report of other investigators.20-22 The implication is that the delivery of an SGA infant should be anticipated in all hypertensive pregnant mothers and strategies should be instituted to prevent the occurrence of the common neonatal problems of such infants (SGA). This approach will also allow for prompt treatment of these problems if they occur. This finding may be explained by the utero-placental insufficiency and inadequate transport of nutrients which hypertension in pregnancy engenders.3 Further analysis according to various subtypes of HDP, showed that although the number was small, 60% of the babies delivered by mothers with chronic hypertension with or without superimposed pre-eclampsia were SGA. This is in sharp contrast with the absence of SGA babies among those delivered by mothers with either transient hypertension or eclampsia. Comparison was not possible because of scarcity of similar studies. This may imply that in subtypes of HDP, which are acute in nature, the disease process has not lasted long enough to severely compromise the placental function with its attendant placental insufficiency and foetal growth restriction. The highest risk of delivery of an SGA baby was found among mothers with chronic hypertension with superimposed pre-eclampsia.  This suggests that chronic hypertension with superimposed pre-eclampsia might be associated with greater degree of reno-vascular compromise with attendant adverse effect on placental development and function.3, 23

Comparison using mean ponderal index revealed that SGA babies born to mothers with chronic hypertension manifested proportionate growth retardation in contrast to disproportionate growth retardation manifested by their counterparts born to mothers with pregnancy-induced hypertension. Similar observation has been previously documented.5 This identification of different patterns of growth retardation is of great potential importance because disproportionate intrauterine growth retarded (IUGR) infants are known to be at a greater risk of neonatal problems of IUGR infants than their proportionate IUGR counterparts. In addition, postnatally, disproportionate IUGR infants have greater early gains in weight, length  and head circumference that proportionate IUGR infants and show a greater tendency to catch up with their normally grown peers.5 Thus, this different patterns of IUGR may influence not only their treatment in the neonatal unit, but also, their post-neonatal follow up. The different patterns of IUGR may be explained by the fact that foetuses experiencing insults early in pregnancy (before 20 weeks gestation as is the case of chronic hypertension) will show alterations in both weight gain and length growth. On the other hand, foetuses experiencing insults later in pregnancy (after 20 weeks gestation, as is the case in pregnancy-induced hypertension) will show a greater reduction in weight gain than in length growth.

In this study, the prevalence of neonatal polycythaemia was significantly higher in babies born to mothers whose pregnancies were complicated by hypertension (8.2%) than in babies of control mothers, indicating the need to routinely check the haematocrits of all infants of hypertensive mothers. Comparison with results of other studies was not possible because they did not state the prevalence of neonatal polycythaemia. The relative foetal hypoxia suffered by the foetus in pregnancy complicated by hypertension stimulates the release of erythropoeitin, which in turn promotes erythropoiesis leading to neonatal polycythaemia. The prevalence of 2.2% being reported here in the control babies falls within the range of 0.45%24 and 4.0%25 reported for otherwise healthy neonates by other investigators. The prevalence of neonatal polycythaemia varied with the subtype of HDP with chronic forms of hypertension being the subtype associated with the highest prevalence of neonatal polycythaemia. This implies that infants born to this category of mothers must be kept under close surveillance for neonatal polycythaemia. It is possible that chronic foetal hypoxia stimulates higher production and release or erythropoietin and hence a greater prevalence of neonatal polycyhaemia.

Acknowledgements

We wish to thank all the consultants in the department of Obstetrics and Gynaecology, UBTH, for permitting us to study their patients. The co-operation we received from the resident doctors and nursing personnel in the antenatal and labour wards is herby acknowledged. We thank Miss Blesyn Efoghe for typing the manuscript. 

References

  1. Gifford RW, August P, Chesley LC. National high blood pressure education program working group Report on blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163:1689-1712
  2. GantNF, Worley RT. Hypertension in pregnancy: Concepts and management. In: Chesley LC (ed) Hypertension in pregnancy. Appleton Century Crofts, New York. 1980; 199-204
  3. Robert JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341 :1447-1451
  4. World Health Organization expert committee. Physical status: The use and interpretation of anthropometry. Wld Hlth Org Techn Rep Ser 1995; 54:124-126
  5. Rosso P. Intrauterine growth retardation. 18th Nestle nutrition workshop series, Rio de Janeiro, Brazil. 1987;  25-28th March
  6. Miller HC, Merit TA. Fetal growth in humans. Year Book, Chicago. 1979
  7. Viller J, Belizan JM. The timing factor in the pathophysiology of the intrauterine growth retardation syndrome. Obstet Gynecol Surv 1982; 37: 499-506
  8. Miller DR. Erythropoiesis, hypoplastic anaemias and disorder of heme synthesis. In: Miller DR, Baehner RL (eds). Blood diseases in infancy and childhood. Mosby, St Louis. 1995; 140-192
  9. Gomella TL, Cunningham MD. Eyai FG (eds). Neonatology: management, procedures, on-call problems, diseases and drugs. Appleton and Lange, Connecticut. 1994; 270-274
  10. 10.     Phibbs RH, Shannon K. Haemotologic problems. In: Klaus MH, Fanaroff AA (eds). Care of the
    high-risk neonate. Saunders, Philadelphia. 1993; 397-425
  11. Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before thirty-sixth week of pregnancy. J Pediatr 1982; 100: 265-271
  12. Cunningham FG, MacDonald P, Gant N, Leveno K, Gilstrap L. Hypertensive disorders in pregnancy. In: Cunningham FG, MacDonald P (eds). William’s obstetrics. Appleton and Lange, Connecticut. 1993; 819-852
  13. Olusanya O. An original system of social classification for use in Nigeria and other developing countries. Paper presented at the 24th Annual Conference of the West African College of Surgeons Freetown, Sierra Leone, 1984
  14. Khan GQ. Pregnancy-induced hypertension: complications and management. Postgraduate Doctors Africa 1987; 9: 20-23
  15. Dubowitz LMS, Dubowitz V, Goldberg C. Clinical assessment of gestational age of the newborn infant. J Pediatr. 1970; 77: 1-10
  16. Miller H, Hassanein K. Diagnosis of impaired fetal growth in newborn infants. Pediatrics 1971; 48: 511-517
  17. Guha DK (ed). Manual of practical newborn care. Jaypee Brothers Medical, New Delhi. 1993; 106-113
  18. Letsky EA. Polycythaemia in the newborn infants. In: Hann IM, Gibson BES, Letsky EA (eds). Fetal and neonatal haematology. Bailliere Tindall, London. 1991; 87-94
  19. Olowe SA. Standards in intrauterine growth for an African population at sea level. J Pediatr 1981; 99: 489-495
  20. Long PA, Abell AA, Beischer NA. Fetal growth retardation and pre-eclemapsia. Br J Obstet Gynaecol 1980; 87: 13-18
  21. Lin C, Lindheimer MD, River P, Moawad AH. Foetal outcome in hypertensive disorder in pregnancy. Am J Obstet Gynecol 1982 ; 112: 255-260
  22. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Pre-clampsia and fetal growth. Obstet Gynecol 2000; 96: 950-955
  23. Ness R, Robert JM. Heterogeneous causes constituting the single syndrome of pre-eclampsia: a hypothesis and its complications. Am J Obstet Gynecol 1996; 175: 1365-1370
  24. Brooks GI, Backes CR. Hyperviscousity secondary to polycythaemia in appropriate-for-gestational age neonates. J Am Osteopath Assoc 1981; 80: 415-418
  25. Ramamurthy RS. Neonatal polycythaemia and hyperviscousity: state of the art. Perinatol Neonatol 1979; 3: 38-40

Copyright 2005 - Annals of African Medicine


The following images related to this document are available:

Photo images

[am05039t1.jpg] [am05039t4.jpg] [am05039t2.jpg] [am05039t3.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil